ES493760A0 - Un procedimiento para preparar benzoxazepinas. - Google Patents

Un procedimiento para preparar benzoxazepinas.

Info

Publication number
ES493760A0
ES493760A0 ES493760A ES493760A ES493760A0 ES 493760 A0 ES493760 A0 ES 493760A0 ES 493760 A ES493760 A ES 493760A ES 493760 A ES493760 A ES 493760A ES 493760 A0 ES493760 A0 ES 493760A0
Authority
ES
Spain
Prior art keywords
benzoxazepines
preparing
procedure
preparing benzoxazepines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES493760A
Other languages
English (en)
Other versions
ES8106730A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of ES8106730A1 publication Critical patent/ES8106730A1/es
Publication of ES493760A0 publication Critical patent/ES493760A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36Seven-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
ES493760A 1978-11-27 1980-07-28 Un procedimiento para preparar benzoxazepinas. Granted ES493760A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14694978A JPS5572177A (en) 1978-11-27 1978-11-27 4,1-benzoxazepine or 4,1-benzothiazepine

Publications (2)

Publication Number Publication Date
ES8106730A1 ES8106730A1 (es) 1981-08-01
ES493760A0 true ES493760A0 (es) 1981-08-01

Family

ID=15419209

Family Applications (4)

Application Number Title Priority Date Filing Date
ES486328A Granted ES486328A0 (es) 1978-11-27 1979-11-26 Un procedimiento para preparar benzoxazepinas
ES493759A Expired ES8106729A1 (es) 1978-11-27 1980-07-28 Un procedimiento para preparar benzoxazepinas
ES493761A Expired ES8106731A1 (es) 1978-11-27 1980-07-28 Un procedimiento para preparar benzoxazepinas
ES493760A Granted ES493760A0 (es) 1978-11-27 1980-07-28 Un procedimiento para preparar benzoxazepinas.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES486328A Granted ES486328A0 (es) 1978-11-27 1979-11-26 Un procedimiento para preparar benzoxazepinas
ES493759A Expired ES8106729A1 (es) 1978-11-27 1980-07-28 Un procedimiento para preparar benzoxazepinas
ES493761A Expired ES8106731A1 (es) 1978-11-27 1980-07-28 Un procedimiento para preparar benzoxazepinas

Country Status (21)

Country Link
US (2) US4297280A (es)
JP (1) JPS5572177A (es)
AR (1) AR227879A1 (es)
AU (1) AU533517B2 (es)
BE (1) BE880282A (es)
CA (1) CA1127639A (es)
CH (1) CH642647A5 (es)
DD (1) DD147360A5 (es)
DE (1) DE2947773A1 (es)
DK (1) DK500179A (es)
ES (4) ES486328A0 (es)
FR (1) FR2442239A1 (es)
GB (1) GB2046729B (es)
HU (1) HU179589B (es)
IT (1) IT1165246B (es)
MX (1) MX6217E (es)
NL (1) NL7908596A (es)
NZ (1) NZ192092A (es)
SE (1) SE7909751L (es)
SU (2) SU936815A3 (es)
ZA (1) ZA796040B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5759893A (en) * 1980-09-29 1982-04-10 Shionogi & Co Ltd 4,1-benzoxazepin derivative
US4374842A (en) * 1980-04-18 1983-02-22 Shionogi & Co., Ltd. 4,1-Benzoxazepines and compositions
CA1211437A (en) * 1981-08-12 1986-09-16 Rene Borer Benzazepines
US4590187A (en) * 1983-11-17 1986-05-20 The Upjohn Company Phospholipase A2 inhibition using 4,1-benzoxazepine-2-(3H)-ones
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
US5552399A (en) * 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
US6063921A (en) * 1997-11-20 2000-05-16 Pharm-Eco Laboratories, Inc. Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1090611A (en) * 1963-05-22 1967-11-08 Lepetit Spa 4,1-benzoxazepine derivatives
DE1545639A1 (de) * 1965-11-19 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Derivaten des 3,5-Dihydro-4,1-Benzothiazepin-2[1 H]-ons
BE793629A (fr) * 1972-01-03 1973-07-03 Upjohn Co Nouveaux derives de benzodiazepines et leur preparation
JPS5084590A (es) * 1973-11-28 1975-07-08
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US3933816A (en) * 1974-09-12 1976-01-20 The Upjohn Company 3-(Substituted aminomethyl)-7-substituted-3,5-dihydro-as-triazino[4,3-a][1,5]benzodiazepines
US3966756A (en) * 1975-04-07 1976-06-29 American Cyanamid Company Substituted dibenzo[b,f]tetrazolo[1,5-d][1,4]-oxazepines
US4246270A (en) * 1976-05-26 1981-01-20 E. I. Du Pont De Nemours And Company 3-Fluorobenzodiazepines and compositions and uses thereof
US4207322A (en) * 1975-11-04 1980-06-10 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler 6-Aryl-s-triazolo-(4,3-alpha)-pyrido-(2,3-f)-(1,4)-diazepines
US4180668A (en) * 1977-06-08 1979-12-25 The Upjohn Company Piperidino-4H-s-triazolo[4,3-a][1,4]benzodiazepines
JPS54119499A (en) * 1978-03-09 1979-09-17 Shionogi & Co Ltd Triazolobenzodiazepin derivative

Also Published As

Publication number Publication date
JPS5572177A (en) 1980-05-30
JPS6231719B2 (es) 1987-07-09
CA1127639A (en) 1982-07-13
GB2046729A (en) 1980-11-19
IT1165246B (it) 1987-04-22
ES493761A0 (es) 1981-08-01
AR227879A1 (es) 1982-12-30
SU936815A3 (ru) 1982-06-15
ES493759A0 (es) 1981-08-01
DE2947773A1 (de) 1980-06-04
ES8106730A1 (es) 1981-08-01
AU533517B2 (en) 1983-12-01
CH642647A5 (de) 1984-04-30
AU5299379A (en) 1980-05-29
US4341704A (en) 1982-07-27
ES8106731A1 (es) 1981-08-01
NZ192092A (en) 1984-07-31
FR2442239A1 (fr) 1980-06-20
US4297280A (en) 1981-10-27
BE880282A (fr) 1980-03-17
NL7908596A (nl) 1980-05-29
DD147360A5 (de) 1981-04-01
SU1005660A3 (ru) 1983-03-15
ES8102106A1 (es) 1980-12-16
FR2442239B1 (es) 1983-07-01
SE7909751L (sv) 1980-05-28
IT7969279A0 (it) 1979-11-26
HU179589B (en) 1982-11-29
ES486328A0 (es) 1980-12-16
MX6217E (es) 1984-12-21
GB2046729B (en) 1983-01-26
ZA796040B (en) 1980-10-29
DK500179A (da) 1980-05-28
ES8106729A1 (es) 1981-08-01

Similar Documents

Publication Publication Date Title
ES476994A0 (es) Procedimiento para preparar perhalociclopropanocarboxilatos.
ES507972A0 (es) Un procedimiento para preparar compuestos de cefem .
ES486786A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
AR221717A1 (es) Un procedimiento para preparar la 17 alfa-butiriloxi-1 beta-hidroxi-21-propioniloxi-4-pregnen-3,20-diona
ES490503A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES479988A0 (es) Un procedimiento para la preparacion de nuevos derivados - hete rociclicos.
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES487847A0 (es) Un procedimiento para preparar nuevas fenetanolaminas
AR222645A1 (es) Procedimiento para preparar un 3-oxo-4alfa,5alfa-epoxi-10,13-dimetil-esteroide-2alfa-carbonitrilo
ES486425A0 (es) Un procedimiento para preparar nuevas 4-arilpiperinas.
ES492003A0 (es) Un procedimiento para preparar compuestos de cefem
ES517459A0 (es) Un procedimiento para preparar un dentifrico estable.
ES497302A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES481478A0 (es) Procedimiento para preparar o-metaliloxifenol.
ES491221A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES490101A0 (es) Un procedimiento para obtener 2,6-diaminonebularinas
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES493760A0 (es) Un procedimiento para preparar benzoxazepinas.
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
ES489590A0 (es) Un procedimiento para preparar arilalquil- y ariloxi-alquil-fosfonatos
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
AR226418A1 (es) Un procedimiento para preparar compuestos de 2,4-dicloro-piridina
ES494226A0 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol